(3,5-Ditert-butyl-4-hydroxyphenyl)methyl-trimethylazanium

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (3,5-Ditert-butyl-4-hydroxyphenyl)methyl-trimethylazanium
• 化学式: C18H32NO+
• 分子量: 278.5
• InChiKey: ZZNMDSFRUBJPPU-UHFFFAOYSA-O

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• Novel benzothiazepine and bensothiepine compounds
  申请人：Sasahara Takehiko

  公开号：US20070190041A1

  公开（公告）日：2007-08-16

  A pharmaceutical useful as a therapeutic agent and a preventive agent for hyperlipemia, and a pharmaceutical useful as a therapeutic agent and a preventive agent for hepatic disorders associated with cholestasis, particularly, primary biliary cirrhosis and primary sclerosing cholangitis, and a pharmaceutical useful as a therapeutic agent and a preventive agent for obesity, fatty liver and steatohepatitis are provided. A benzothiazepine or benzothiepine compound represented by the following formula (1A) having a thioamide bond and a quaternary ammonium substitutent:

  提供了一种药物，可用作治疗和预防高脂血症的治疗剂和预防剂，以及一种药物，可用作治疗和预防与胆汁淤积有关的肝脏疾病，特别是原发性胆汁性肝硬化和原发性硬化性胆管炎的治疗剂和预防剂，以及一种药物，可用作治疗和预防肥胖症、脂肪肝和脂肪性肝炎的治疗剂和预防剂。化合物的苯并噻吩或苯并噻环代表如下式（1A），具有硫酰胺键和季铵取代基：
• Novel quaternary ammonium compounds
  申请人：Sasahara Takehiko

  公开号：US20070203115A1

  公开（公告）日：2007-08-30

  A method for inhibiting ileal bile acid transporter activity in a subject, comprising administering to said subject an effective amount of a compound represented by formula (1):

  一种抑制回肠胆汁酸转运蛋白活性的方法，包括向该受试者施用一种由式（1）所代表的化合物的有效量：
• NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS
  申请人：SASAHARA Takehiko

  公开号：US20120015925A1

  公开（公告）日：2012-01-19

  A pharmaceutical useful as a therapeutic agent and a preventive agent for hyperlipemia, and a pharmaceutical useful as a therapeutic agent and a preventive agent for hepatic disorders associated with cholestasis, particularly, primary biliary cirrhosis and primary sclerosing cholangitis, and a pharmaceutical useful as a therapeutic agent and a preventive agent for obesity, fatty liver and steatohepatitis are provided. A benzothiazepine or benzothiepine compound represented by the following formula (1A) having a thioamide bond and a quaternary ammonium substituent:

  提供了一种作为治疗剂和预防剂用于高脂血症的药物，以及一种作为治疗剂和预防剂用于与胆汁淤积相关的肝疾病，特别是原发性胆汁性肝硬化和原发性硬化性胆管炎的药物，以及一种作为治疗剂和预防剂用于肥胖症、脂肪肝和脂肪性肝炎的药物。该药物是一种具有硫酰胺键和季铵基取代基的苯并噻吩或苯并噻吩化合物，其化学式为（1A）。
• CONDUCTIVE FILM FORMING COMPOSITION, CONDUCTIVE FILM, ORGANIC THIN FILM TRANSISTOR, ELECTRONIC PAPER, DISPLAY DEVICE, AND WIRING BOARD
  申请人：FUJIFILM CORPORATION

  公开号：US20170174914A1

  公开（公告）日：2017-06-22

  The present invention provides a conductive film forming composition which makes it possible to prepare an organic thin film transistor having excellent insulation reliability while inhibiting the deterioration of mobility and has excellent coating properties and provides a conductive film and an organic thin film transistor which are prepared using the composition. The present invention also provides electronic paper and a display device which contain the organic thin film transistor and wiring board which has wiring formed using the conductive film forming composition. The conductive film forming composition according to the present invention contains water, conductive particles, and a migration inhibitor containing a compound having a group represented by Formula (1). In Formula (1), W 1 represents any one of a hydrogen atom, Formula (A), Formula (B), and Formula (C). In Formula (1), R 1 , R 2 , R 3 , and R 4 each independently represent any one of a hydrogen atom, a substituent, and W 2 . W 2 represents Formula (D), Formula (E), or Formula (F). Here, in a case where W 1 is a hydrogen atom, at least one of R 1 , R 2 , R 3 , or R 4 is W 2 . In Formula (1), * represents a binding position.
• US7312208B2
  申请人：——

  公开号：US7312208B2

  公开（公告）日：2007-12-25